FIBROGEN INC — Director's Dealing 2016

Dec 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-12-14

Reporting Person: Yu K Peony (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-14	Common Stock	S	2344	$20.65	Disposed	207448	Direct

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.